• Tiamulin (Thiamutilin): Reliable Solutions for Cell-Based As

  2026-05-30

  This article delivers a scenario-driven, evidence-based guide to Tiamulin (Thiamutilin) (SKU BA1083) for cell viability, proliferation, and cytokine modulation assays. By addressing real laboratory challenges and integrating quantitative data, it helps researchers optimize workflows using this pleuromutilin antibiotic and anti-inflammatory agent.

• Lopinavir (ABT-378): Mechanistic Leverage in Translational H

  2026-05-29

  This thought-leadership article explores the mechanistic, experimental, and strategic dimensions of Lopinavir (ABT-378) in HIV and emerging viral pathogen research. It integrates molecular rationale, protocol recommendations, and translational insight, drawing on recent findings in both HIV protease inhibition and cross-domain antiviral repurposing.

• Cy5 TSA Fluorescence System Kit: Sensitive Detection via HRP

  2026-05-29

  The Cy5 TSA Fluorescence System Kit enables rapid, ultrasensitive detection of low-abundance targets in immunohistochemistry and in situ hybridization using horseradish peroxidase catalyzed tyramide deposition. This article details the biological rationale, mechanism, and quantitative benchmarks, clarifying optimal use and typical misconceptions.

• Tumor-Selective PAD4 Inhibition via m-PBA Modification Suppr

  2026-05-28

  This study introduces a meta-phenylboronic acid (m-PBA)-modified PAD4 inhibitor (Compound 5i TFA) that achieves highly selective uptake in tumor cells, efficiently inhibits histone H3 citrullination, and suppresses neutrophil extracellular trap (NET) formation. The findings provide a new strategy for targeting the PAD4-H3cit-NETs axis in tumor progression while minimizing systemic toxicity.

• Kanamycin Sulfate: Mechanistic Insights & Data-Driven Select

  2026-05-28

  Explore Kanamycin Sulfate as a water-soluble antibiotic through a rigorous, evidence-backed lens. This article delivers advanced mechanistic analysis and practical selection criteria for microbiology and antibiotic resistance research.

• Re-evaluating ACE Inhibitors: Selectivity for Aminopeptidase

  2026-05-27

  The reference study systematically compares the inhibitory actions of ACE inhibitors and related metallopeptidase inhibitors on mammalian aminopeptidases N, A, and W. Its critical innovation is the direct side-by-side evaluation of inhibitor selectivity, clarifying which agents target specific peptidases and informing the design and interpretation of cardiovascular and hypertension research models.

• YTHDF2 Inhibition Enhances Protein Synthesis and Memory in M

  2026-05-27

  This study reveals that targeted inhibition of YTHDF2-mediated m6A mRNA degradation in the mouse forebrain leads to increased synaptic protein synthesis and improved hippocampus-dependent memory performance. The findings offer mechanistic insight into how m6A reader proteins regulate neural plasticity and open avenues for novel cognitive intervention strategies.

• Bismuth Subsalicylate: Advanced Protocols for GI Research

  2026-05-26

  Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) enables robust, reproducible workflows in gastrointestinal disorder research by uniquely targeting prostaglandin pathways and providing reliable performance in both inflammation and apoptosis models. This guide translates the latest reference innovations and APExBIO’s product strengths into actionable protocol enhancements and troubleshooting strategies.

• Scenario-Driven Best Practices with HOBt (1-Hydroxybenzotria

  2026-05-26

  This article addresses common laboratory challenges in peptide synthesis and amide bond formation, providing evidence-based strategies for minimizing epimerization and maximizing reproducibility. Learn how HOBt (1-Hydroxybenzotriazole) (SKU A7025) from APExBIO delivers high-purity, workflow-compatible solutions tailored for biomedical research assays.

• Targeting Senescent Tumor Cells with BH3 Mimetics in TP53 Wi

  2026-05-26

  This study demonstrates that BH3 mimetic drugs, by selectively inducing apoptosis in chemotherapy-induced senescent breast cancer cells with functional TP53, can enhance tumor regression and survival. The findings provide a mechanistic rationale for targeting BCL-XL/BCL-XL–MCL1 survival pathways to overcome resistance associated with tumor cell senescence.

• Tiamulin (Thiamutilin): Metabolism, PK/PD, and Assay Precisi

  2026-05-25

  Explore the advanced metabolic profiling and pharmacokinetics of Tiamulin (Thiamutilin), a pleuromutilin antibiotic for veterinary use. This article uniquely focuses on interspecies metabolism, assay optimization, and practical insights for precise experimental design.

• Nutlin-3a as an MDM2 Inhibitor: Enhanced Protocols for Cance

  2026-05-24

  Nutlin-3a enables precise, reproducible activation of the p53 pathway in cancer cell models, facilitating robust studies of cell cycle arrest and apoptosis induction. By integrating workflow optimizations and troubleshooting tips, researchers can address common assay challenges and leverage advanced insights from the latest glioblastoma research.

• Pyridostatin TFA in G-Quadruplex and TDP-43 Research Workflo

  2026-05-23

  Pyridostatin TFA, a robust G-quadruplex DNA structure stabilizer, is transforming experimental approaches in telomere biology, cancer, and neurodegenerative disease research. This guide distills advanced protocols, troubleshooting strategies, and key innovations to help research teams maximize reproducibility and insight when deploying Pyridostatin in cellular and molecular models.

• Decoding Colonic Barrier Failure: DSS Models and Repair Circ

  2026-05-22

  Explore how Dextran sulfate sodium salt (MW 35000-45000) empowers translational researchers to dissect epithelial damage and repair in ulcerative colitis. This thought-leadership article bridges mechanistic insights—such as GPR35-KLF5 metabolic gatekeeping—with actionable guidance for optimizing DSS mouse models, advancing both assay performance and clinical relevance.

• 7ACC2 and Immunometabolic Control: A New Era in Tumor Microe

  2026-05-22

  Discover how 7ACC2, a potent monocarboxylate transporter 1 inhibitor, advances cancer metabolism research by targeting both lactate and pyruvate transport. This article uniquely connects MCT1 inhibition to immunometabolic reprogramming of the tumor microenvironment.

461 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page